Condition: Postpartum Hemorrhage · Sponsor: London School of Hygiene and Tropical Medicine
Heavy bleeding after childbirth, known as a postpartum haemorrhage (PPH), causes about 70,000 maternal deaths every year. Tranexamic acid (TXA) is a lifesaving treatment for women with PPH. The I'M WOMAN trial is a research study to see whether giving TXA just before childbirth will stop women developing PPH. The trial will assess the effects of intramuscular (IM) and intravenous (IV) tranexamic acid on PPH, side effects and other important maternal health outcomes.
This description comes directly from the study's public registry record.
Amy Brenner · +44 (0)20 7958 8283 · imwoman@lshtm.ac.uk
Ian Roberts · +44 (0)20 7958 8128
Always discuss trial participation with your own doctor first.
| Mbeya Regional Referral Hospital | Mbeya, Tanzania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05562609